Exotoxins of Staphylococcus aureus

Clinical Microbiology Reviews

Volumn 13, Issue 1, 2000, Pages 16-34

  Dinges, Martin M ^a   Orwin, Paul M ^a   Schlievert, Patrick M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; BETA HEMOLYSIN; DELTA HEMOLYSIN; ENDOTOXIN; GAMMA HEMOLYSIN; HEMOLYSIN; LEUKOCIDIN; PYROGENIC TOXIN SUPERANTIGEN; SPHINGOMYELIN PHOSPHODIESTERASE; STAPHYLOCOCCUS ENTEROTOXIN; SUPERANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; CLINICAL FEATURE; CYTOKINE RELEASE; FOOD POISONING; NONHUMAN; PATHOGENESIS; STAPHYLOCOCCUS AUREUS; STRUCTURE ANALYSIS; TAMPON; TOXIC SHOCK SYNDROME; TOXIN ANALYSIS;

POSIBACTERIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0033962325     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.13.1.16-34.2000     Document Type: Article

References (182)

1. Acharya, K. R., E. F. Passalacqua, E. Y. Jones, K. Harlos, D. I. Stuart, R. D. Brehm, and H. S. Tranter. 1994. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature 367:94-97.
2. Alber, G., D. Hammer, and B. Fleischer. 1990. Relationship between enterotoxic-and T lymphocyte-stimulating activity of staphylococcal enterotoxin B. J. Immunol. 144:4501-4506.
3. Alber, G., P. H. Scheuber, B. Reck, B. Sailer-Kramer, A. Hartmann, and D. K. Hammer. 1989. Role of substance P in immediate-type skin reactions induced by staphylococcal enterotoxin B in unsensitized monkeys. J. Allergy Clin. Immunol. 84:880-885.
4. Altemeier, W. A., S. A. Lewis, P. M. Schlievert, M. S. Bergdoll, H. J. Bjornson, J. L. Staneck, and B. A. Crass. 1982. Staphylococcus aureus associated with toxic shock syndrome: phage typing and toxin capability tested. Ann. Intern. Med. 96:978-982.
5. Araake, M., T. Uchiyama, K. Imanishi, and X. J. Yan. 1991. Activation of human vascular endothelial cells by IFN-gamma: acquisition of HLA class II expression, TSST-1-binding activity and accessory activity in T cell activation by the toxin. Int. Arch. Allergy Appl. Immunol. 96:55-61.
6. Arvidson, S., L. Janzon, and S. Lofdahl. 1990. The role of the δ-hemolysin gene (hld) in the agr-dependent regulation of exoprotein synthesis in Staphylococcus aureus, p. 419-431. In R. P. Novick (ed.), Molecular biology of the staphylococci. VCH Publishers Inc., New York, N.Y.
7. Beery, J. T., S. Taylor, L. R. Schlunz, R. C. Freed, and M. S. Bergdoll. 1994. Effects of staphylococcal enterotoxin A on the rat gastrointestinal tract. Infect. Immun. 44:234-240.
8. Beisel, W. R. 1972. Pathophysiology of staphylococcal enterotoxin, type B, (SEB) toxemia after intravenous administration to monkeys. Toxicon 10: 433-440.
9. Belmonte, G., L. Cescatti, B. Ferrari, T. Nicolussi, M. Ropele, and G. Menestrina. 1987. Pore-formation by Staphylococcus aureus alpha-toxin in lipid bilayers: temperature and toxin concentration dependence. Eur. J. Biophys. 14:349-358.
10. Bergdoll, M. S. 1983. Enterotoxins, p. 559-598. In C. S. F. Easmon and C. Adlam (ed.), Staphylococci and staphylococcal infections. Academic Press, Ltd., London, United Kingdom.
11. Bergdoll, M. S., B. A. Crass, R. F. Reiser, R. N. Robbins, and J. P. Davis. 1981. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic shock syndrome Staphylococcus aureus isolates. Lancet i:1017-1021.
12. Bergdoll, M. S., R. N. Robbins, K. Weiss, C. R. Borja, I. Y. Huang, and F. S. Chu. 1973. The staphylococcal enterotoxins: similarities. Contrib. Microbiol. Immunol. 1:390-396.
13. Bergdoll, M. S., and P. M. Schlievert. 1984. Toxic-shock syndrome toxin. Lancet ii:691.
14. Bernheimer, A. W., L. S. Avigad, and K. S. Kim. 1974. Staphylococcal sphingomyelinase (beta hemolysin). Ann. N. Y. Acad. Sci. 236:292-306.
15. Bernheimer, A. W., and L. L. Schwartz. 1963. Isolation and composition of staphylococcal alpha toxin. J. Gen. Microbiol. 30:455.
16. Bhakdi, S., M. Muhly, and R. Fussle. 1984. Correlation between toxin binding and hemolytic activity in membrane damage by staphylococal α-toxin. Infect. Immun. 46:318-323.
17. Bhakdi, S., M. Muhly, U. Mannhardt, F. Hugo, K. Klapettek, C. Muller-Eckhardt, and L. Roka. 1988. Staphylococcal α-toxin promotes blood coagulation via attack on human platelets. J. Exp. Med. 168:527-542.
18. Bhakdi, S., and J. Tranum-Jensen. 1991. Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 55:733-751.
19. Birbeck, T. H., and J. H. Freer. 1988. Purification and assay of staphylococcal δ-lysin. Methods Enzymol. 165:16-22.
20. Blanco, L., E. M. Choi, K. Connolly, M. R. Thompson, and P. F. Bonventre. 1990. Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody. Infect. Immun. 58:3020-3028.
21. Blomster-Hautamaa, D. A., B. N. Kreiswirth, J. S. Kornblum, R. P. Novick, and P. M. Schlievert. 1986. The nucleotide and partial amino acid sequence of toxic-shock syndrome toxin-1. J. Biol. Chem. 261:15783-15786.
22. Blomster-Hautamaa, D. A., B. N. Kreiswirth, R. P. Novick, and P. M. Schlievert. 1986. The resolution of highly purified toxic-shock syndrome toxin-1 (TSST-1) into two distinct proteins by isoelectric focusing. Biochemistry 25:54-59.
23. Blomster-Hautamaa, D. A., and P. M. Schlievert. 1988. Purification of toxic-shock syndrome toxin-1. Methods Enzymol. 165:37-43.
24. Bohach, G. A., D. J. Fast, R. D. Nelson, and P. M. Schlievert. 1990. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit. Rev. Microbiol. 17:251-272.
25. Bohach, G. A., L. M. Jablonski, C. F. Deobald, Y. I. Chi, and C. V. Stauffacher. 1995. Functional domains of staphylococcal enterotoxins, p. 339-356. In M. Ecklund, J. L. Richard, and K. Mise (ed.), Molecular approaches to food safety: issues involving toxic microorganisms. Alaken Inc., Fort Collins, Colo.
26. Bohach, G. A., M. M. Dinges, D. T. Mitchell, D. H. Ohlendorf, and P. M. Schlievert. 1997. Exotoxins, p. 83-111. In K. B. Crossley and G. L. Archer (ed.), The staphylococci in human disease. Churchill Livingstone, Inc., New York, N.Y.
27. Bohach, G. A., L. Jablonski, M. Roggiani, I. Sadler, P. M. Schlievert, D. Mitchell, and D. Ohlendorf. 1998. Biological activity of pyrogenic toxins delivered at the mucosal surface, p. 170-172. In J. Arbuthnott and B. Furman (ed.), European Conference on Toxic Shock Syndrome. International Congress and Symposium Series 229. Royal Society of Medicine Press Ltd., New York, N.Y.
28. Bonventre, P. F., H. Heeg, C. Cullen, and C. Lian. 1993. Toxicity of recombinant toxic shock syndrome toxin I and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Infect. Immun. 61:793-799.
29. Bonventre, P. F., H. Heeg, C. D. Edwards III, and C. M. Cullen. 1995. A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minima toxicity. Infect. Immun. 63:509-515.
30. Campbell, W. N., M. Fitzpatrick, X. Ding, M. Jett, P. Liemski, and S. E. Goldblum. 1997. SEB is cytotoxic and alters EC barrier function through protein tyrosine phosphorylation in vitro. Am. J. Physiol. 273:L31-L39.
31. Canonico, P. G., and M. J. Van Zweiten. 1971. Swelling of mitochondria from rabbit liver induced by staphylococcal enterotoxin B. J. Infect. Dis. 124:372-378.
32. Centers for Disease Control and Prevention. 1997. Case definitions for infectious conditions under public health surveillance. Morbid. Mortal. Weekly Rep. 46(RR-10):1-55.
33. Chesney, P. J. 1989. Clinical aspects and spectrum of illness of toxic shock syndrome: overview. Rev. Infect. Dis. 11:S1-S7.
34. Chesney, P. J. 1997. Toxic shock syndrome, p. 509-525. In K. B. Crossley and G. L. Archer (ed.), The staphylococci in human disease. Churchill Livingstone, Inc., New York, N.Y.
35. Chesney, R. W., P. J. Chesney, J. P. Davis, and W. E. Segar. 1981. Renal manifestations of the staphylococcal toxic-shock syndrome. Am. J. Med. 71:583-588.
36. Chesney, R. W., D. M. McCarron, J. G. Haddad, C. D. Hawker, F. P. DiBella, P. J. Chesney, and J. P. Davis. 1983. Pathogenic mechanisms of the hypocalcemia of the staphylococcal toxic-shock syndrome. J. Lab. Clin. Med. 101:576-585.
37. Cheung, A. L., J. M. Koomey, C. A. Butler, S. J. Projan, and V. A. Fischetti. 1992. Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc. Natl. Acad. Sci. USA 89:6462-6466.
38. Choi, Y., J. A. Lafferty, J. R. Clements, J. K. Todd, E. W. Gelfand, J. Kappler, P. Marrack, and B. L. Kotzin. 1990. Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J. Exp. Med. 172:981-984.
39. Coleman, D. C., J. P. Arbuthnott, H. M. Pomeroy, and H. Birbeck. 1986. Cloning and expression in Escherichia coli and Staphylococcus aureus of the beta-lysin determinant from Staphylococcus aureus: evidence that bacteriophage conversion of beta-lysin activity is caused by insertional inactivation of the beta-lysin determinant. Microb. Pathog. 1:549-564.
40. Colin, D. A., I. Mazurier, S. Sire, and V. Finck-Barbancon. 1994. Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation. Infect. Immun. 62:3184-3188.
41. Cone, L. A., D. R. Woodard, R. G. Byrd, K. Schulz, S. M. Kopp, and P. M. Schlievert. 1991. A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS. J. Infect. Dis. 165:638-643.
42. Couch, J. L., M. T. Soltis, and M. J. Betley. 1988. Cloning and nucleotide sequence of the type E staphylocoocal enterotoxin gene. J. Bacteriol. 170: 2954-2960.
43. Davis, J. P., P. J. Chesney, P. J. Wan, M. LaVenture, and Investigation and Laboratory Team. 1980. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N. Engl. J. Med. 303:1429-1435.
44. Deresiewicz, R. L. 1996. Staphylococcal toxic shock syndrome, p. 435-479. In D. Y. M. Leung, B. T. Huber, and P. M. Schlievert (ed.), Superantigens: molecular biology, immunology and relevance to human disease. Marcel Dekker, Inc., New York, N.Y.
45. Dhople, V. M., and R. Nagaraj. 1993. δ-toxin, unlike melittin, has only hemolytic activity and no antimicrobial activity: rationalization of this specific biological activity. Biosci. Rep 13:245-250.
46. Reference deleted.
47. Dinges, M., J. Jessurun, and P. Schlievert. 1998. Comparisons of mouse and rabbit models of toxic shock syndrome, p. 167-168. In J. Arbuthnott and B. Furman (ed.), European Conference on Toxic Shock Syndrome. International Congress and Symposium Series 229. Royal Society of Medicine Press Ltd., New York, N.Y.
48. Doery, H. M., B. J. Magnuson, I. M. Cheyne, and J. Galasekharam. 1963. A phospholipase in staphylococcal toxin which hydrolizes sphingomyelin. Nature (London) 198:1091-1093.
49. Doery, H. M., B. J. Magnuson, J. Galasekharam, and J. E. Pearson. 1965. The properties of phospholipase enzymes in staphylococcal toxins. J. Gen. Microbiol. 40:283-296.
50. Driessen, C., K. Hirv, H. Kircherner, and L. Rink. 1995. Zinc regulates cytokine induction by superantigens and lipopolysaccharide. Immunology 84:272-277.
51. Earhart, C. A., G. S. Prasad, D. L. Murray, R. P. Novick, P. M. Schlievert, and D. H. Ohlendorf. 1993. Growth and analysis of crystal forms of toxic shock syndrome toxin-1. Proteins 17:329-334.
52. Earhart, C. A., D. T. Mitchell, D. L. Murray, D. M. Pinheiro, M. Matsumara, P. M. Schlievert, and D. H. Ohlendorf. 1998. Structures of five mutants of toxic shock syndrome toxin-1 with reduced biological activity. Biochemistry 37:7194-7202.
53. Edwin, C., and E. H. Kass. 1989. Identification of functional antigenic segments of toxic shock syndrome toxin 1 by differential immunoreactivity and by differential mitogenic responses of human peripheral blood mononuclear cells using active toxin fragments. Infect. Immun. 57:2230-2236.
54. Fields, B. A., E. L. Malchiodi, L. X. Y. Hongmin, C. V. Stauffacher, P. M. Schlievert, K. Karjalainen, and R. A. Mariuzza. 1996. Crystal structure of a T-cell receptor B-chain complexed with a superantigen. Nature 384:188-192.
55. Fleischer, B., and H. Schrezenmeier. 1988. T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J. Exp. Med. 167:1697-1707.
56. Fraser, J. D., S. Lowe, M. J. Irwin, N. R. J. Gascoigne, and K. R. Hudson. 1993. Structural model of staphylococcal enterotoxin A interaction with MHC class II antigens, p. 7-29. In B. T. Huber and E. Palmer (ed.), Superantigens: a pathogen's view of the immune system. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
57. Freer, J. H., and J. P. Arbuthnott. 1983. Toxins of Staphylococcus aureus. Pharmacol. Ther. 19:55-106.
58. Freer, J. H., and T. H. Birbeck. 1982. Possible conformation of delta-lysin, a membrane-damaging peptide of Staphylococcus aureus. J. Theor. Biol. 94:535-540.
59. Fujikawa, H., H. Igarashi, H. Usami, S. Tanaka, and H. Tamura. 1986. Clearance of endotoxin from blood of rabbits injected with staphylococcal toxic shock syndrome toxin-1. Infect. Immun. 52:134-137.
60. Glenny, A. T., and N. F. Stevens. 1935. Staphylococcal toxins and antitoxins. J. Pathol. Bacteriol. 40:201-210.
61. Gottfried, A., P. H. Scheuber, B. Reck, B. Sailer-Kramer, A. Hartmann, and D. K. Hammer. 1989. Role of substance P in immediate-type skin reactions induced by staphylococcal enterotoxin B in unsensitized monkeys. J. Allergy Clin. Immunol. 84:880-885.
62. Gouaux, E. 1998. α-Hemolysin from Staphylococcus aureus: an archetype of β-barrel, channel forming toxins. J. Struct. Biol. 121:110-122.
63. Gouaux, J. E., O. Braha, M. R. Hobaugh, L. Song, S. Cheley, C. Shustak, and H. Bayley. 1994. Subunit stoichiometry of staphylococcal alpha-hemolysin in crystals and on membranes: a heptameric transmembrane pore. Proc. Natl. Acad. Sci. USA 91:12828-12831.
64. Gourley, G. R., P. J. Chesney, J. P. Davis, and G. B. Odell. 1981. Acute cholestasis in patients with toxic shock syndrome. Gastroenterology 81:928-931.
65. Gray, G. S., and M. Kehoe. 1984. Primary sequence of the α-toxin gene from Staphylococcus aureus Wood 46. Infect. Immun. 46:615-618.
66. Hamad, A. R., P. Marrack, and J. W. Kappler. 1997. Transcytosis of staphylococcal superantigen toxins. J. Exp. Med. 185:1447-1454.
67. Harris, T. O., D. Grossman, J. W. Kappler, P. Marrack, R. R. Rich, and M. J. Betley. 1993. Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Infect. Immun. 61: 3175-3183.
68. Harshman, S., N. Sugg, and P. Cassiday. 1988. Preparation and purification of staphylococcal alpha toxin. Methods Enzymol. 165:3-7.
69. Hildebrand, A., M. Roth, and S. Bhakdi. 1991. Staphylococcus aureus alpha-toxin: dual mechanisms of binding to target cells. J. Biol. Chem. 266:17195-17200.
70. Hoffmann, M. L., L. M. Jablonski, K. K. Crum, S. P. Hackett, Y. I. Chi, C. V. Stauffacher, D. L. Stevens, and G. A. Bohach. 1994. Predictions of T-cell receptor and major histocompatibility complex binding sites on staphylococcal enterotoxin C1. Infect. Immun. 62:3396-3407.
71. Holmberg, S. D., and P. A. Blake. 1984. Staphylococcal food poisoning in the United States. JAMA 251:487-489.
72. Hovde, C. J., J. C. Marr, M. L. Hoffmann, S. P. Hackett, Y. I. Chi, K. K. Crum, D. L. Stevens, C. V. Stauffacher, and G. A. Bohach. 1994. Investigation of the role of the disulfide bond in activity and structure of staphylococcal enterotoxin C1. Mol. Microbiol. 13:897-909.
73. Hurley, J. M., R. Shimonkevitz, A. Hanagan, K. Enney, E. Boen, S. Mahmstrom, B. L. Kotzin, and M. Matsumura. 1995. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1. J. Exp. Med. 181:2229-2235.
74. Iandolo, J. J. 1989. Genetic analysis of extracellular toxins of Staphylococcus aureus. Annu. Rev. Microbiol. 43:375-402.
75. Ikejima, T., S. Okusawa, J. W. van der Meer, and C. A. Dinarello. 1988. Induction by toxic-shock-syndrome-toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells. J. Infect. Dis. 158: 1017-1025.
76. Jardetzky, T. S., J. H. Brown, J. C. Gorga, L. J. Stern, R. G. Urban, Y. I. Chi, C. V. Stauffacher, J. L. Strominger, and D. C. Wiley. 1994. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature (London) 368:711-718.
77. Jett, M., W. Brinkley, R. Neill, P. Gemski, and R. Hunt. 1990. Staphylococcus aureus enterotoxin B challenge of monkeys: correlation of plasma levels of arachidonic acid cascade products with occurrence of illness. Infect. Immun. 58:3494-3499.
78. Jonas, D., I. Walev, T. Berger, M. Liebetrau, M. Palmer, and S. Bhakdi. 1994. Novel path to apoptosis: small transmembrane pores created by staphylococcal alpha-toxin in T lymphocytes evoke internucleosomal DNA degradations. Infect. Immun. 62:1304-1312.
79. Kamio, Y., A. Rahman, H. Nariya, T. Ozawa, and K. Izaki. 1993. The two staphylococcal bi-component toxins, leukocidin and gamma-hemolysin, share one component in common. FEBS Lett. 321:15-18.
80. Kass, E. H., J. Parsonnet, and J. T. Mills. 1987. Role of magnesium ions in the pathogenesis of toxic shock syndrome. Trans. Assoc. Am. Physiol. 100:158-163.
81. Kass, E. H., P. M. Schlievert, J. Parsonnet, and J. T. Mills. 1988. Effect of magnesium on production of toxic-shock syndrome toxin-1: a collaborative study. J. Infect. Dis. 158:44-51.
82. Keane, W. F., G. Gekker, P. M. Schlievert, and P. K. Peterson. 1986. Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin 1. Am. J. Pathol. 122:169-176.
83. Kent, T. H. 1966. Staphylococcal enterotoxin gastroenteritis in rhesus monkeys. Am. J. Pathol. 48:387-407.
84. Kim, J., R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 266:1870-1874.
85. Komisar, J., J. Rivera, A. Vega, and J. Tseng. 1992. Effects of staphylococcal enterotoxin B on rodent mast cells. Infect. Immun. 60:2969-2975.
86. Konig, B., G. Prevost, and W. Konig. 1997. Composition of staphylococcal bi-component toxins determines pathophysiological reactions. J. Med. Microbiol. 46:479-485.
87. Kotzin, B. L., D. Y. Leung, J. Kappler, and P. Marrack. 1993. Superantigens and their potential role in human disease. Adv. Immunol. 54:99-166.
88. Krakauer, T. 1994. Cell adhesion molecules are co-receptors for staphylococcal enterotoxin B-induced T-cell activation and cytokine production. Immunol. Lett. 39:121-125.
89. Kreger, A. S., K. S. Kim, F. Zoboretsky, and A. W. Bernheimer. 1971. Purification and properties of staphylococcal delta hemolysin. Infect. Immun. 3:449-465.
90. Kushnaryov, V. M., H. S. MacDonald, R. F. Reiser, and M. S. Bergdoll. 1989. Reaction of toxic shock syndrome toxin 1 with endothelium of human umbilical cord vein. Rev. Infect. Dis. 11:S282-S288.
91. Ladhani, S., C. L. Joannou, D. P. Lochrie, R. W. Evans, and S. M. Poston. 1999. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin. Microbiol. Rev. 12: 224-242.
92. Larkin, S. M., D. N. Williams, M. T. Osterholm, R. W. Tofte, and Z. Posalaky. 1982. Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases. Ann. Intern. Med. 96:858-864.
93. Lee, K. H., J. E. Fitton, and K. Wuthrich. 1987. Nuclear magnetic resonance investigation of the conformation of δ-haemolysin bound to dodecylphosphocholine micelles. Biochim. Biophys. Acta 911:144-153.
94. Lee, P. K., and P. M. Schlievert. 1989. Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness. J. Clin. Microbiol. 27:1890-1892.
95. Lee, P. K., J. R. Deringer, B. N. Kreiswirth, R. P. Novick, and P. M. Schlievert. 1991. Fluid replacement and polymyxin B protection of rabbits challenged subcutaneously with toxic shock syndrome toxins. Infect. Immun. 59:879-884.
96. Lee, P. K., B. N. Kreiswirth, J. R. Deringer, S. J. Projan, W. Eisner, B. L. Smith, E. Carlson, R. P. Novick, and P. M. Schlievert. 1992. Nucleotide sequences and biological properties of toxic shock syndrome toxin-1 from ovine-and bovine-associated Staphylococcus aureus. J. Infect. Dis. 165: 1056-1063.
97. Lee, P. K., G. M. Vercellotti, J. R. Deringer, and P. M. Schlievert. 1991. Effects of staphylococcal toxic shock syndrome toxin-1 on aortic endothelial cells. J. Infect. Dis. 164:711-719.
98. Leist, M., F. Gantner, I. Bohlinger, P. G. Germann, G. Tiegs, and A. Wendel. 1994. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J. Immunol. 153:1778-1788.
99. Leonard, B. A. B., and P. M. Schlievert. 1992. Immune cell lethality induced by streptococcal pyrogenic exotoxin A and endotoxin. Infect. Immun. 60: 3747-3755.
100. Leung, D. Y. M., H. C. Meissner, D. R. Fulton, D. L. Murray, B. L. Kotzin, and P. M. Schlievert. 1993. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 342:1385-1388.
101. Li, H., A. Liera, D. Tsuchiya, L. Leder, X. Ysern, P. M. Schlievert, K. Karjalainen, and R. A. Mariuzza. 1998. Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity 9:807-816.
102. Lindsay, J. A., A. Ruzin, H. F. Ross, N. Kurepina, and R. P. Novick. 1998. The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol. Microbiol. 29:527-543.
103. Low, D. K. R., and J. H. Freer. 1977. The purification of β-lysin (sphingomyelinase C) from Staphylococcus aureus. FEMS Lett. 2:139-143.
104. MacDonald, K. L., M. T. Osterholm, C. W. Hedberg, C. G. Schrock, G. F. Peterson, J. M. Jentzen, S. A. Leonard, and P. M. Schlievert. 1987. Toxic shock syndrome. A newly recognized complication of influenza and influenza-like illness. JAMA 257:1053-1058.
105. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705-711.
106. Marrack, P., and J. Kappler. 1990. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp. Med. 171:455-464.
107. Melish, M., C. Fukunaga, and S. Murata. 1998. TSST-1 dissemination in a vaginal model for TSS, p. 169. In J. Arbuthnott and B. Furman (ed.), European Conference on Toxic Shock Syndrome. International Congress and Symposium Series 229. Royal Society of Medicine Press Ltd., New York, N.Y.
108. Melish, M. E., S. Murata, C. Fukunaga, K. Frogner, S. Hirata, and C. Wong. Endotoxin is not an essential mediator of toxic shock syndrome. Rev. Infect. Dis. 11:8219-5230.
109. Mellor, I. R., D. H. Thomas, and M. S. P. Sansom. 1988. Properties of ion channels formed by Staphylococcus aureus δ-toxin. Biochim. Biophys. Acta. 942:280-294.
110. Miethke, T., K. Duschek, C. Wahl, K. Heeg, and H. Wagner. 1993. Pathogenesis of toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1. Eur. J. Immunol. 23:1294-1500.
111. Murray, D. L., C. A. Earhart, D. T. Mitchell, D. H. Ohlendorf, R. P. Novick, and P. M. Schlievert. 1996. Localization of biologically important regions on toxic shock syndrome toxin-1. Infect. Immun. 64:371-374.
112. Murray, D. L., G. S. Prasad, C. A. Earhart, B. A. B. Leonard, B. N. Kreiswirth, R. P. Novick, D. H. Ohlendorf, and P. M. Schlievert. 1994. Immunobiological and biochemical properties of mutants of toxic shock syndrome toxin-1. J. Immunol. 152:87-95.
113. Nagaki, M., Y. Muto, H. Ohnishi, S. Yasuda, K. Sano, T. Naito, T. Maeda, T. Yamada, and M. Hisataka. 1994. Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology 106:450-458.
114. Neill, R. J., M. Jett, R. Crane, J. Wootres, C. Welch, D. Hoover, and P. Gemski. 1996. Mitogenic activities of amino acid substitution mutants of staphylococcal enterotoxin B in human and mouse lymphocyte cultures. Infect. Immun. 64:3007-3015.
115. Newbould, M. J., J. Malam, J. M. McIllmurray, J. A. Morris, D. R. Telford, and A. J. Barson. 1989. Immunohistological localization of staphylococcal toxic syndrome (TSST-1) antigen in sudden infant death syndrome. J. Clin. Pathol. 42:935-939.
116. Noda, M., and I. Kato. 1988. Purification and crystallization of staphylococcal leukocidin. Methods Enzymol. 165:22-32.
117. Novick, R., J. Lindsay, A. Ruzin, and H. Ross. 1998. Molecular genetics of the tst element, a mobile pathogenicity island in Staphylococcus aureus., p. 109-112. In J. Arbuthnott and B. Furman (ed.), European Conference on Toxic Shock Syndrome. International Congress and Symposium Series 229. Royal Society of Medicine Press Ltd., New York, N.Y.
118. Ohlsen, K., K. P. Koller, and J. Hacker. 1997. Analysis of expression of the alpha-toxin gene (hla) of Staphylococcus aureus by using a chromosomally encoded hla:lacZ gene fusion. Infect. Immun. 65:3606-3614.
119. O'Reilly, M., B. N. Kreiswirth, and T. J. Foster. 1990. Molecular analysis of a nonexpressed α-toxin gene (hla) of clinical isolates of Staphylococcus aureus, p. 439-443. In R. P. Novick (ed.), Molecular biology of the staphylococci. VCH Publishers Inc, New York, N.Y.
120. Osterholm, M. T., J. P. Davis, R. W. Gibson, C. Mandel, J. Rondeau, J. M. Vergeront, and The Investigation Team. 1982. Tri-state toxic-shock syndrome study. I. Epidemiologic findings. J. Infect. Dis. 145:431-440.
121. Paliard, X., S. G. West, J. A. Lafferty, J. R. Clements, J. W. Kappler, P. Marrack, and B. L. Kotzin. 1991. Evidence of the effects of a superantigen in rheumatoid arthritis. Science 253:325-329.
122. Papageorgiou, A. C., K. R. Acharya, R. Shapiro, R. Passalacqua, R. D. Brehm, and H. S. Tranter. 1995. Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site. Structure 3:769-779.
123. Paris, A. L., L. A. Herwaldt, D. Blum, G. P. Schmid, K. N. Shands, and C. V. Broome. 1982. Pathologic findings in twelve fatal cases of toxic shock syndrome. Ann. Intern. Med. 96:852-857.
124. Parsonnet, J. 1998. Case definition of staphylococcal TSS: A proposed revision incorporating laboratory findings, p. 15. In J. Arbuthnott and B. Furman (ed.), European Conference on Toxic Shock Syndrome. International Congress and Symposium Series 229. Royal Society of Medicine Press Ltd., New York, N.Y.
125. Parsonnet, J., Z. A. Gillis, A. G. Richter, and G. B. Pier. 1987. A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect. Immun. 55:1070-1076.
126. Parsonnet, J., P. A. Modern, and K. D. Giacobbe. 1996. Effect of tampon composition on production of toxic shock syndrome toxin-1 by Staphylococcus aureus in vitro. J. Infect. Dis., 173:98-103.
127. Peng, H. L., R. P. Novick, B. Kreiswirth, J. Kornblum, and P. Schlievert. 1988. Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. J. Bacteriol. 170:4365-4372.
128. Plommet, M. 1988. Preparation and purification of γ-hemolysin of staphylococci. Methods Enzymol. 165:8-16.
129. Poindexter, N. J., and P. M. Schlievert. 1985. Toxic shock syndrome toxin-1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes. J. Infect. Dis. 151:65-72.
130. Prasad, G. S., C. A. Earhart, D. L. Murray, R. P. Novick, P. M. Schlievert, and D. H. Ohlendorf. 1993. Structure of toxic shock syndrome toxin-1. Biochemistry 32:13761-13766.
131. Prasad, G. S., R. Radhakrishnan, D. T. Mitchell, C. A. Earhart, M. M. Dinges, W. J. Cook, P. M. Schlievert, and D. H. Ohlendorf. 1997. Refined structures of three crystal forms of toxic shock syndrome toxin-1 and of a tetramutant with reduced activity. Protein Sci. 6:1220-1227.
132. Prevost, G., P. Couppie, P. Prevost, S. Gayet, P. Petiau, B. Cribier, H. Monteil, and Y. Piemont. 1995. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J. Med. Microbiol. 42:237-245.
133. Prevost, G., B. Cribier, P. Couppie, P. Petiau, G. Supersac, V. Finck-Barbancon, H. Monteil, and Y. Piemont. 1995. Panton-Valentine leukocidin and gamma hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect. Immun. 63:4121-4129.
134. Projan, S. J., J. Kornblum, B. Kreiswirth, S. L. Moghazeh, W. Eisner, R. P. Novick. 1989. Nucleotide sequence: the β-hemolysin gene of Staphylococcus aureus. Nucleic Acids Res. 17:3305.
135. Rago, J. V., and P. M. Schlievert. 1998. Scalded skin syndrome. Rev. Med. Microbiol. 9:9-15.
136. Reck, B., P. H. Scheuber, W. Londong, B. Sailer-Kramer, K. Bartsch, and D. K. Hammer. 1988. Protection against the staphylococcal enterotoxin-induced intestinal disorder in the monkey by anti-idiotypic antibodies. Proc. Natl. Acad. Sci. USA 85:3170-3174.
137. Recsei, P., B. Kreiswirth, M. O'Reilly, P. Schlievert, A. Gruss, and R. P. Novick. 1986. Regulation of exoprotein gene expression in Staphylococcus aureus by agr. Mol. Gen. Genet. 202:58-61.
138. Regelmann, W. E., E. D. Gray, and L. W. Wannamaker. 1982. Characterization of the human cellular immune response to purified group A streptococcal blastogen A. J. Immunol. 128:1631-1636.
139. Reingold, A. L., C. V. Broome, S. Gaventa, A. W. Hightower, and Toxic Shock Study Group. 1989. Risk factors for menstrual toxic shock syndrome: results of a multistate case-control study. Rev. Infect. Dis. 11(Suppl. 1): S35-S41.
140. Reingold, A. L., N. T. Hargrett, B. B. Dan, K. N. Shands, B. Y. Strickland, and C. V. Broome. 1982. Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann. Intern. Med. 96:871-874.
141. Sauter, C., and C. Wolfensberger. 1980. Interferon in human serum after injection of endotoxin. Lancet 11:852-853.
142. Schad, E. M., I. Zaitseva, V. N. Zaitsev, M. Dohlsten, T. Kalland, P. M. Schlievert, D. H. Ohlendorf, and L. A. Svensson. 1995. Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J. 14:3292-3301.
143. Scheuber, P. H., J. R. Golecki, B. Kickhofen, D. Scheel, G. Beck, and D. K. Hammer. 1987. Cysteinyl leukotrienes as mediators of staphylococcal enterotoxin B in the monkey. Eur. J. Clin. Investig. 17:455-459.
144. Reference deleted.
145. Schlievert, P. M. 1982. Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect. Immun. 36:123-128.
146. Schlievert, P. M. 1983. Alteration of immune function by staphylococcal pyrogenic exotoxin type C: possible role in toxic-shock syndrome. J. Infect. Dis. 147:391-398.
147. Schlievert, P. M. 1986. Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly assoc ated with nonmenstrual TSS. Lancet i:1149-1150.
148. Schlievert, P. M. 199.5. Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin. J. Infect. Dis. 172:1112-1114.
149. Schlievert, P. M. 1995. Role of superantigens in human diseases. Curr. Opin. Infect. Dis. 8:170-174.
150. Schlievert, P. M. 1998. Incidence studies of toxic shock syndrome, p. 34-36. In J. Arbuthnott and B. Furman (ed.), European Conference on Toxic Shock Syndrome. International Congress and Symposium Series 229. Royal Society of Medicine Press, Ltd., New York, N.Y.
151. Schlievert, P. M., K. M. Bettin, and D. W. Watson. 1980. Inhibition of ribonucleic acid synthesis by group A streptococcal pyrogenic exotoxin. Infect. Immun. 27:542-548.
152. Schlievert, P. M., and D. A. Blomster. 1983. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J. Infect. Dis. 147:236-242.
153. Schlievert, P. M., G. A. Bohach, D. H. Ohlendorf, C. V. Stauffacher, D. Y. M. Leung, D. L. Murray, S. P. Prasad, C. A. Earhart, L. M. Jablonski, M. L. Hoffmann, and Y. I. Chi. 1995. Molecular structure of staphylococcus and streptococcus superantigens. J. Clin. Immunol. 15:4S-10S.
154. Schlievert, P. M., K. N. Shands, B. B. Dan, G. P. Schmid, and R. D. Nishimura. 1981. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J. Infect. Dis. 143:509-516.
155. Schwab, J. H., R. R. Brown, S. K. Anderle, and P. M. Schlievert. 1993. Superantigen can reactivate bacterial cell wall-induced arthritis. J. Immunol. 150:4151-4159.
156. Schwab, J. H., D. W. Watson, and J. Cromartie. 1955. Further studies of group A streptococcal factors with lethal and cardiotoxic properties. J. Infect. Dis. 96:14-18.
157. Seeger, W., M. Bauer, and S. Bhakdi. 1990. Staphylococcal alpha-toxin induced vascular leakage in isolated perfused rabbit lungs. Lab. Investig. 63:341-349.
158. Shands, K. N., G. P. Schmid, B. B. Dan, D. Blum, R. J. Guidotti, N. T. Hargrett, R. L. Anderson, D. L. Hill, C. V. Broome, J. D. Band, and D. W. Fraser. 1980. Toxic-shock syndrome in menstruating women: its association with tampon use and Staphylococcus aureus and the clinical features in 52 cases. N. Engl. J. Med. 303:1436-1442.
159. Siqueira, J. A., C. Speeg-Schatz, F. I. S. Frehas, J. Sahel, H. Monteil, and G. Prevost. 1997. Channel-forming leucotoxins from Staphylococcus aureus cause severe inflammatory reactions in a rabbit eye model. J. Med. Microbiol. 46:486-494.
160. Six, H., and S. Harshman. 1973. Purification and properties of two forms of staphylococcal α-toxin. Biochemistry 12:2672-2683.
161. Smith, M. L., and S. A. Price. 1938. Staphylococcus γ-haemolysin. J. Pathol. Bacteriol. 47:379-393.
162. Spero, L., B. A. Morlock, and J. F. Metzger. 1978. On the cross-reactivity of staphylococcal enterotoxins A, B, C1. J. Immunol. 120:86-89.
163. Stolz, S. J., J. P. Davis, J. M. Vergeront, B. A. Crass, P. J. Chesney, P. J. Wand, and M. S. Bergdoll. 1985. Development of serum antibody to toxic shock syndrome toxin among individuals with toxic shock syndrome in Wisconsin. J. Infect. Dis. 151:883-889.
164. Stone, R. L., and P. M. Schlievert. 1987. Evidence tor the involvement of endotoxin in toxic shock syndrome. J. Infect. Dis. 155:682-689.
165. Sugiyama, H., and T. Hayama. 1965. Abdominal viscera as site of emetic action for staphylococcal enterotoxin in the monkey. J. Infect. Dis. 115: 330-336.
166. Supersac, G., G. Prevost, and Y. Piemont. 1993. Sequencing of leucocidin R from Staphylococcus aureus P83 suggests that staphylococcal leucocidins and gamma-hemolysin are members of a single, two-component family of toxins. Infect. Immun. 61:580-587.
167. Suttorp, N., W. Seeger, E. Dewein, S. Bhakdi, and L. Roka. 1985. Staphylococcal α-toxin-induced-PGI2 in endothelial cells: role of calcium. Am. J. Physiol. 248:C127-C134.
168. Swaminathan, S., W. Furey, J. Pletcher, and M. Sax. 1992. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature (London) 359:801-806.
169. Thelestam, M., and R. Mollby. 1975. Determination of toxin induced leakage of different size nucleotides through the plasma membrane of human diploid fibroblasts. Infect. Immun. 11:640-648.
170. Tierno, P. M., and B. A. Hanna. 1994. Propensity of tampons and barrier contraceptives to amplify Staphylococcus aureus toxic shock syndrome toxin-1. Infect. Dis. Obstet. Gynecol. 2:140-145.
171. Todd, J., M. Fishaut, F. Kapral, and T. Welch. 1978. Toxic shock syndrome associated with phage-group-I staphylococci. Lancet ii:1116-1118.
172. Todd, J. K., B. H. Todd, A. Franco-Buff, C. M. Smith, and D. W. Lawellin. 1987. Influence of focal growth conditions of the pathogenesis of toxic shock syndrome. J. Infect. Dis. 155:673-681.
173. Uchiyama, T., X. J. Araake, Y. Yan, Y. Miyanaga, and H. Igarashi. 1992. Involvement of HLA class II molecules in acquisition of staphylococcal enterotoxin A-binding activity and accessory cell activity in activation of human T cells by related toxins in vascular endothelial cells. Clin. Exp. Immunol. 87:322-328.
174. Valeva, A., M. Palmer, and S. Bhakdi. 1997. Staphylococcal exotoxin: formation of the heptameric pore is cooperative and proceeds through multiple intermediate stages. Biochemistry 36:13298-13304.
175. Vandana, S., M. Raje, and M. V. Krishnasastry. 1997. The role of the amino terminus in the kinetics and assembly of a hemolysin of Staphylococcus aureus. J. Biol. Chem. 272:24858-24863.
176. Vergeront, J. M., S. J. Stolz, B. A. Crass, D. B. Nelson, J. P. Davis, and M. S. Bergdoll. 1983. Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic shock syndrome. J. Infect. Dis. 148:692-698.
177. Walev, I., E. Martin, D. Jonas, M. Mohamadzadeh, W. Muller-Klieser, L. Kunz, and S. Bhakdi. 1993. Staphylococcal alpha-toxin kills human keratinocytes by permeabilizing the plasma membrane for monovalent ions. Infect. Immun. 61:4972-4979.
178. Wagner, G., L. Bohr, P. Wagner, and L. N. Perterson. 1984. Tampon-induced changes in vaginal oxygen and carbon dioxide tension. Am. J. Obstet. Gynecol. 148:147-150.
179. Woodin, A. M. 1959. Fractionation of the two components of leukocidin from Staphylococcus aureus. Biochem. J. 73:225-237.
180. Woodin, A. M. 1960. Purification of the two components of leukocidin from Staphylococcus aureus. Biochem. J. 75:158-165.
181. Yamada, A., N. Tsukagoshi, S. Udaka, T. Sasaki, S. Makino, S. Nakamura, C. Little, M. Tomita, and H. Ikezawa. 1988. Nucleotide sequence and expression in Escherichia coli of the gene coding for sphingomyelinase of Bacillus subtilis. Eur. J. Biochem. 175:213-220.
182. Zhang, S., J. J. Iandolo, and G. C. Stewart. 1998. The enterotoxin D plasmid of Staphylococcus aureus encodes a second enterotoxin determinant (sej). FEMS Microbiol. Lett. 168:227-233.